Allurion Technologies, Inc. (ALUR)
(Delayed Data from NYSE)
$1.12 USD
-0.11 (-8.94%)
Updated Jun 17, 2024 04:00 PM ET
After-Market: $1.12 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth C Momentum B VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ALUR 1.12 -0.11(-8.94%)
Will ALUR be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for ALUR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALUR
Allurion (ALUR) Unveils Positive Data for Its Balloon Therapy
Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ALUR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ALUR
12 Consumer Discretionary Stocks Moving In Friday's Intraday Session
Sidoti Events, LLC's Virtual June Small-Cap Conference
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery
Allurion Announces the Appointment of Ojas A. Buch as Chief Operating Officer
Allurion Technologies names Ojas Buch as new COO